156 related articles for article (PubMed ID: 25009659)
1. CD1d levels in peripheral blood of patients with acute myeloid leukemia and acute lymphoblastic leukemia.
Guo W; Dong A; Xing C; Lin X; Pan X; Lin Y; Zhu B; He M; Yao RX
Oncol Lett; 2014 Aug; 8(2):825-830. PubMed ID: 25009659
[TBL] [Abstract][Full Text] [Related]
2. Numbers and cytotoxicities of CD3+CD56+ T lymphocytes in peripheral blood of patients with acute myeloid leukemia and acute lymphocytic leukemia.
Guo W; Xing C; Dong A; Lin X; Lin Y; Zhu B; He M; Yao R
Cancer Biol Ther; 2013 Oct; 14(10):916-21. PubMed ID: 24030391
[TBL] [Abstract][Full Text] [Related]
3. Generation of CD3+ CD56+ cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells.
Hongeng S; Petvises S; Worapongpaiboon S; Rerkamnuaychoke B; Pakakasama S; Jootar S
Int J Hematol; 2003 Feb; 77(2):175-9. PubMed ID: 12627854
[TBL] [Abstract][Full Text] [Related]
4. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
Baer MR; Stewart CC; Lawrence D; Arthur DC; Byrd JC; Davey FR; Schiffer CA; Bloomfield CD
Blood; 1997 Aug; 90(4):1643-8. PubMed ID: 9269784
[TBL] [Abstract][Full Text] [Related]
5. [Expression of Tim-3 on natural killer cells in patients with acute myeloid leukemia and its clinical significance].
Ma JF; Li CX; Wu DP; Sun ZL; Yan CL
Zhonghua Xue Ye Xue Za Zhi; 2019 Sep; 40(9):755-758. PubMed ID: 31648478
[No Abstract] [Full Text] [Related]
6. Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T-cell distribution.
Vidriales MB; Orfao A; López-Berges MC; González M; Hernandez JM; Ciudad J; López A; Moro MJ; Martínez M; San Miguel JF
Ann Hematol; 1993 Nov; 67(5):217-22. PubMed ID: 7694663
[TBL] [Abstract][Full Text] [Related]
7. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689
[TBL] [Abstract][Full Text] [Related]
8. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics of T-cell immunity in patients with acute leukemia].
Parovichnikova EN; Gal'tseva IV; Vorob'ev IA; Savchenko VG
Ter Arkh; 2006; 78(7):18-25. PubMed ID: 16944746
[TBL] [Abstract][Full Text] [Related]
10. [Detection and Analysis of T Lymphocyte Subsets and B Lymphocytes in Patients with Acute Leukemia].
Cheng J; Ma HZ; Zhang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):327-330. PubMed ID: 30998133
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
12. [Clinical Features and Prognosis of 227 cases of Acute Myeloid Leukemia with Cross-lineage Antigen Expression].
Fang F; Zhu P; Zhang Y; Lu XZ; Dong YJ; Sun YH; Wang LH; Bu DF; Cen XN; Wang MJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):990-7. PubMed ID: 27531762
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 6B11 mAb and α-GalCer-loaded CD1d dextramers for detection of iNKT cells by flow cytometry.
Lenart M; Gruca A; Mueck A; Rutkowska-Zapała M; Surman M; Szaflarska A; Kobylarz K; Baran J; Siedlar M
J Immunol Methods; 2017 Jul; 446():1-6. PubMed ID: 28365328
[TBL] [Abstract][Full Text] [Related]
14. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
15. The monocyte tumor necrosis factor-alpha production in patients with acute leukemia in complete remission.
Aiso M; Iizuka Y; Kang HI; Sawada S; Ohshima T; Horie T
Med Oncol Tumor Pharmacother; 1992; 9(4):191-7. PubMed ID: 1342064
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells.
Metelitsa LS; Weinberg KI; Emanuel PD; Seeger RC
Leukemia; 2003 Jun; 17(6):1068-77. PubMed ID: 12764370
[TBL] [Abstract][Full Text] [Related]
17. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
[TBL] [Abstract][Full Text] [Related]
18. The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.
Rettinger E; Kuçi S; Naumann I; Becker P; Kreyenberg H; Anzaghe M; Willasch A; Koehl U; Bug G; Ruthardt M; Klingebiel T; Fulda S; Bader P
Cytotherapy; 2012 Jan; 14(1):91-103. PubMed ID: 21973023
[TBL] [Abstract][Full Text] [Related]
19. [Intracellular cytokine expression characteristics of activated T lymphocytes in patients with acute myeloid leukemia].
Yang HZ; Wang J; Sun ZM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1161-4. PubMed ID: 18088457
[TBL] [Abstract][Full Text] [Related]
20. Tim-3 expression on peripheral monocytes and CD3+CD16/CD56+natural killer-like T cells in patients with chronic hepatitis B.
Rong YH; Wan ZH; Song H; Li YL; Zhu B; Zang H; Zhao Y; Liu HL; Zhang AM; Xiao L; Xin SJ; You SL
Tissue Antigens; 2014 Feb; 83(2):76-81. PubMed ID: 24397461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
